Niclosamide (GMP)

Overview

Niclosamide (GMP) is Niclosamide ( HY-B0497 ) produced by using GMP guidelines. GMP small molecules work appropriately as an auxiliary reagent for cell therapy manufacture. Niclosamide (BAY2353) is an orally active antihelminthic agent used in parasitic infection research. Niclosamide is a STAT3 inhibitor with an IC 50 of 0.25 μM in HeLa cells. Niclosamide has biological activities against cancer , inhibits DNA replication in Vero E6 cells.

Application

Products | Products > GMP Small Molecules | Products > Signaling Pathways > Anti-infection | Products > Signaling Pathways > Stem Cell/Wnt | Products > Signaling Pathways > JAK/STAT Signaling | Products > Research Areas > Cancer > Cancer Immunotherapy | Products > Research Areas > Cancer > Cancer Stem Cells | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Signaling Pathways > Antibiotic | Products > Signaling Pathways > STAT | Products > Signaling Pathways > Parasite

Product Information

• Catalog No.: HY-B0497G
• CAS No.: 50-65-7
• Molecular Formula: C13H8Cl2N2O4
• Molecular Weight: 327.12
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source